Published in Biol Psychiatry on September 15, 2010
Animal models to guide clinical drug development in ADHD: lost in translation? Br J Pharmacol (2011) 0.91
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. J Neurochem (2011) 0.90
Transgenic mouse models for ADHD. Cell Tissue Res (2013) 0.88
Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders. Mol Psychiatry (2014) 0.87
Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors. J Neurosci (2014) 0.87
Differential effects of methylphenidate and cocaine on GABA transmission in sensory thalamic nuclei. J Neurochem (2013) 0.84
Forebrain-specific deletion of Cdk5 in pyramidal neurons results in mania-like behavior and cognitive impairment. Neurobiol Learn Mem (2013) 0.79
At the Fulcrum in Health and Disease: Cdk5 and the Balancing Acts of Neuronal Structure and Physiology. Brain Disord Ther (2012) 0.79
A new treatment for cognitive disorders related to in utero exposure to alcohol. Neural Regen Res (2013) 0.78
A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5. Mol Neurobiol (2016) 0.76
Aberrant Monoaminergic System in Thyroid Hormone Receptor-β Deficient Mice as a Model of Attention-Deficit/Hyperactivity Disorder. Int J Neuropsychopharmacol (2015) 0.75
Cdk5 Modulates Long-Term Synaptic Plasticity and Motor Learning in Dorsolateral Striatum. Sci Rep (2016) 0.75
Biological functions of CDK5 and potential CDK5 targeted clinical treatments. Oncotarget (2017) 0.75
Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in Alzheimer's disease model. J Cell Sci (2017) 0.75
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A (2007) 5.56
Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA (2002) 4.72
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A (1996) 4.16
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev (1992) 4.03
Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron (1996) 4.00
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci (2007) 3.82
Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med (1990) 3.80
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50
Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci (2000) 3.10
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature (2001) 3.09
Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron (1997) 2.96
Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1997) 2.89
DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature (1984) 2.74
Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry (2006) 2.72
A brain-specific activator of cyclin-dependent kinase 5. Nature (1994) 2.71
The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev (1996) 2.59
Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat Neurosci (2007) 2.56
Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res (1986) 2.47
Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics (2010) 2.35
Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci (2000) 2.18
Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry (1994) 2.08
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature (2002) 1.91
Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci (2008) 1.85
Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry (2008) 1.79
Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci (1998) 1.72
Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60
Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J Neurosci (2007) 1.49
Neurobiology of ADHD. Neuropharmacology (2009) 1.46
Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine. Proc Natl Acad Sci U S A (2007) 1.42
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry (2005) 1.40
Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry (2000) 1.30
Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology (2004) 1.30
Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry (2007) 1.25
Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res (1994) 1.21
Calcium influx through subunits GluR1/GluR3 of kainate/AMPA receptor channels is regulated by cAMP dependent protein kinase. EMBO J (1992) 1.21
Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc Natl Acad Sci U S A (2004) 1.16
Positron emission tomography study of regional cerebral metabolism in humans during isoflurane anesthesia. Anesthesiology (1997) 1.15
Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice. Science (2000) 1.13
Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability. J Biol Chem (2004) 1.07
A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol (1998) 1.07
High-resolution brain SPECT imaging in ADHD. Ann Clin Psychiatry (1997) 1.04
Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4). Am J Med Genet (1999) 1.00
Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther (1998) 0.99
Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. J Pharmacol Exp Ther (1989) 0.96
Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry (2004) 0.96
Cocaine sensitization: modulation by dopamine D2 receptors. Cereb Cortex (2002) 0.94
Forebrain overexpression of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD. Proc Natl Acad Sci U S A (2010) 0.94
Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry (1994) 0.93
Identification of tyrosine hydroxylase as a physiological substrate for Cdk5. J Neurochem (2004) 0.93
Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5. PLoS One (2009) 0.91
Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry (2006) 0.91
Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain. J Nucl Med (1995) 0.91
Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology (Berl) (1998) 0.88
Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. J Pharmacol Exp Ther (2001) 0.87
Dentate development in organotypic hippocampal slice cultures from p35 knockout mice. Dev Neurosci (2007) 0.85
Association between Dopamine D4 Receptor Gene Polymorphism and Scores on a Continuous Performance Test in Korean Children with Attention Deficit Hyperactivity Disorder. Psychiatry Investig (2009) 0.84
Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. J Neurochem (2003) 0.84
Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C. Eur J Pharmacol (2008) 0.83
Changes in the expression of novel Cdk5 activator messenger RNA (p39nck5ai mRNA) during rat brain development. Neurosci Res (1997) 0.83
Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function. Eur J Pharmacol (1995) 0.82
Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Eur J Pharmacol (1994) 0.81
Aberrant activation of CDK5 is involved in the pathogenesis of OPIDN. J Neurochem (2006) 0.80
Autonomic and behavioral effects of dextroamphetamine and placebo in normal and hyperactive prepubertal boys. J Abnorm Child Psychol (1980) 0.78
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell (2007) 8.99
alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol (2002) 6.64
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem (2004) 4.86
PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med (2004) 4.50
Electrical synapses in the mammalian brain. Annu Rev Neurosci (2004) 3.66
Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem (2004) 3.57
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature (2010) 2.49
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis (2009) 2.49
Electrical synapses in the thalamic reticular nucleus. J Neurosci (2002) 2.47
Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci U S A (2010) 2.16
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature (2002) 1.91
Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res (2004) 1.89
Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry (2009) 1.87
Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J Neurosci (2009) 1.87
The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci (2005) 1.86
Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci (2008) 1.85
The mouse polyubiquitin gene UbC is essential for fetal liver development, cell-cycle progression and stress tolerance. EMBO J (2007) 1.56
Ghrelin mediates stress-induced food-reward behavior in mice. J Clin Invest (2011) 1.50
Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J Neurosci (2007) 1.49
Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine. Proc Natl Acad Sci U S A (2007) 1.42
Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Ed Engl (2011) 1.41
Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem (2011) 1.41
Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockΔ19 mouse model of mania. Neuropsychopharmacology (2011) 1.37
64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med (2005) 1.35
Cdk5 is essential for adult hippocampal neurogenesis. Proc Natl Acad Sci U S A (2008) 1.34
Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. J Neurochem (2002) 1.32
Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol (2002) 1.32
The role of Cdk5 in neuroendocrine thyroid cancer. Cancer Cell (2013) 1.30
A beta3-adrenergic-leptin-melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress. Biol Psychiatry (2010) 1.24
Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors. NMR Biomed (2012) 1.23
Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem (2005) 1.20
The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. Mol Pharm (2008) 1.18
Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J Neurosci (2003) 1.16
Imparting multivalency to a bifunctional chelator: a scaffold design for targeted PET imaging probes. Angew Chem Int Ed Engl (2009) 1.14
Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics. Angew Chem Int Ed Engl (2012) 1.14
Transplantation of mesenchymal stem cells from young donors delays aging in mice. Sci Rep (2011) 1.13
Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice. J Neurochem (2005) 1.09
MRI detection of VEGFR2 in vivo using a low molecular weight peptoid-(Gd)8-dendron for targeting. J Am Chem Soc (2010) 1.08
Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS One (2009) 1.07
Wireless neural stimulation in freely behaving small animals. J Neurophysiol (2009) 1.05
Neuroanatomy of melanocortin-4 receptor pathway in the lateral hypothalamic area. J Comp Neurol (2012) 1.05
Chronic social defeat stress disrupts regulation of lipid synthesis. J Lipid Res (2010) 1.04
Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology. Proc Natl Acad Sci U S A (2008) 1.04
The effect of the amide substituent on the biodistribution and tolerance of lanthanide(III) DOTA-tetraamide derivatives. Invest Radiol (2008) 1.04
Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease. Mol Imaging Biol (2012) 1.03
Role of Cdk5 in drug abuse and plasticity. Ann N Y Acad Sci (2004) 1.03
Novel synthetic ligands for targeted PET imaging and radiotherapy of copper. Bioorg Med Chem Lett (2007) 1.02
Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav Brain Res (2011) 1.01
Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression. Am J Nucl Med Mol Imaging (2011) 1.01
Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J Biol Chem (2006) 1.01
Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol J (2007) 1.00
Labeling of adenovirus particles with PARACEST agents. Bioconjug Chem (2008) 0.99
Melanocortin 4 receptor signaling in dopamine 1 receptor neurons is required for procedural memory learning. Physiol Behav (2012) 0.99
Regulation of protein phosphatase inhibitor-1 by cyclin-dependent kinase 5. J Biol Chem (2007) 0.99
Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J Biol Chem (2006) 0.98
Advances in molecular imaging of pancreatic beta cells. Front Biosci (2008) 0.98
Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain. J Neurochem (2006) 0.98
Eating disorder predisposition is associated with ESRRA and HDAC4 mutations. J Clin Invest (2013) 0.97
Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B. PLoS One (2011) 0.97
Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. Nucl Med Biol (2006) 0.96
Transcriptional activation of low-density lipoprotein receptor gene by DJ-1 and effect of DJ-1 on cholesterol homeostasis. PLoS One (2012) 0.94
Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications. Mol Cancer Ther (2009) 0.94
Parkin-dependent degradation of the F-box protein Fbw7β promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1. Mol Cell Biol (2013) 0.93
The role of Cdk5 in cognition and neuropsychiatric and neurological pathology. Brain Res Bull (2010) 0.93
Identification of tyrosine hydroxylase as a physiological substrate for Cdk5. J Neurochem (2004) 0.93
A cell permeable peptide analog as a potential-specific PET imaging probe for prostate cancer detection. Amino Acids (2010) 0.92
Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5. PLoS One (2009) 0.91
Striatal signal transduction and drug addiction. Front Neuroanat (2011) 0.91
Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol (2006) 0.91
Phosphorylation of protein phosphatase inhibitor-1 by protein kinase C. J Biol Chem (2006) 0.91
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. J Neurochem (2011) 0.90
Phospholipase D family member 4, a transmembrane glycoprotein with no phospholipase D activity, expression in spleen and early postnatal microglia. PLoS One (2010) 0.90
Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression. J Nucl Med (2009) 0.90
Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice. Proc Natl Acad Sci U S A (2013) 0.89
Translational neuroscience approaches to hyperphagia. J Neurosci (2010) 0.89
Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart. Circ Res (2011) 0.89
Gold nanotags for combined multi-colored Raman spectroscopy and x-ray computed tomography. Nanotechnology (2010) 0.88
Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains. Mol Neurodegener (2009) 0.88
A role for ΔFosB in calorie restriction-induced metabolic changes. Biol Psychiatry (2011) 0.88
Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency. Bioconjug Chem (2011) 0.88
Cdk5 and the mystery of synaptic vesicle endocytosis. J Cell Biol (2003) 0.87
Number and brightness analysis of LRRK2 oligomerization in live cells. Biophys J (2012) 0.87
Analysis of oligo-arginine cell-permeable peptides uptake by prostate cells. Amino Acids (2010) 0.87
Molecular determinants of energy homeostasis. Am J Psychiatry (2006) 0.86
Hippocampal pyramidal neurons switch from a multipolar migration mode to a novel "climbing" migration mode during development. J Neurosci (2014) 0.86